ArticleFrontiers in immunology2024

Case report: Disitamab vedotin combined with immunotherapy demonstrated excellent efficacy in scrotal Paget's disease with Her-2 overexpression.

Jia-Ling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.